Frederick, MD, United States of America

David Cassatt


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by David Cassatt

Introduction

David Cassatt is an accomplished inventor based in Frederick, MD (US). He holds three patents that focus on improving the administration of amifostine and related compounds for patients undergoing radiation therapy or chemotherapy. His work aims to enhance patient care by minimizing the side effects associated with conventional treatment methods.

Latest Patents

One of David Cassatt's latest patents is titled "Methods for the administration of amifostine and related compounds." This invention provides innovative methods for administering amifostine, WR-1065, or a combination thereof, to patients receiving radiation therapy or chemotherapy. The methods significantly reduce or decrease the adverse side effects of these compounds compared to traditional intravenous administration. This patent reflects his commitment to improving patient outcomes in oncology.

Career Highlights

Throughout his career, David Cassatt has made significant contributions to the field of oncology. He has worked with notable companies such as MedImmune Oncology, Inc. and MedImmune Limited. His experience in these organizations has allowed him to develop and refine his innovative approaches to patient care.

Collaborations

David has collaborated with various professionals in the field, including Christine A Fazenbaker. Their joint efforts have contributed to advancements in the administration of cancer treatments.

Conclusion

David Cassatt's work exemplifies the impact of innovation in the medical field, particularly in oncology. His patents and career achievements highlight his dedication to improving patient care through advanced treatment methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…